Wendy W. Hu

发表

High dose etoposide‐based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma

R. Negrin, N. Chao, G. Long, 1996, Cancer.

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.

J. Wingard, B. Andersson, S. Forman, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.

J. Niland, J. Wingard, B. Andersson, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.

L. Deangelis, J. Cairncross, S. Rosenfeld, 2006, Neuro-oncology.

High-dose Chemotherapy with Stem Cell Rescue as Initial Therapy for Anaplastic Oligodendroglioma

L. Deangelis, J. Cairncross, S. Rosenfeld, 2003, Journal of Neuro-Oncology.

Rapid engraftment after allogeneic transplantation of density‐enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies

R. Negrin, S. Strober, F. Valone, 2001, Cancer.

Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation.

J. Dipersio, D. Douer, S. Giralt, 2003, The oncologist.

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.

H. Deeg, R. Storb, W. Leisenring, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of oral glutamine supplementation during bone marrow transplantation.

R. Negrin, J. Shizuru, K. Stockerl-Goldstein, 2000, JPEN. Journal of parenteral and enteral nutrition.

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.

S. Horning, B. W. Brown, R. Hoppe, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.

S. Horning, R. Negrin, N. Chao, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

S. Horning, B. W. Brown, R. Hoppe, 1997, Blood.

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer.

I. Weissman, R. Negrin, K. Atkinson, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary infections after bone marrow transplantation: clinical and radiographic findings.

A. Leung, M. Gosselin, S. Braun, 1999, Radiology.

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.

M. Amylon, R. Negrin, N. Chao, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.

S. Horning, B. W. Brown, R. Negrin, 1995, Blood.

Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.

A. Nademanee, J. Niland, K. Gould, 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.

R. Negrin, N. Rizk, J. Shizuru, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.

S. Horning, M. Amylon, B. W. Brown, 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

J. Wingard, B. Andersson, H. Fernandez, 2000, Bone Marrow Transplantation.

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.

R. Negrin, J. Shizuru, K. Stockerl-Goldstein, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.